{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:48:21Z","timestamp":1760060901684,"version":"build-2065373602"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1053\/j.semdp.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:10:35Z","timestamp":1682428235000},"page":"223-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of immunohistochemical studies in diagnosing emerging superficial mesenchymal neoplasms"],"prefix":"10.1053","volume":"40","author":[{"given":"Kasey J.","family":"McCollum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-0530","authenticated-orcid":false,"given":"Rami N.","family":"Al-Rohil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0001","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.path.2021.03.002","article-title":"Update on Cutaneous Soft Tissue Tumors","volume":"14","author":"Dermawan","year":"2021","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cup.13870","article-title":"EWSR1-SMAD3 rearranged fibroblastic tumor: case series and review","volume":"48","author":"Habeeb","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.semdp.2022.02.004","article-title":"Immunohistochemical and molecular updates in cutaneous soft tissue neoplasms","volume":"39","author":"Chukwudebe","year":"2022","journal-title":"Seminars in Diagnostic Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.012_bib0004","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/PAS.0000000000001109","article-title":"EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic\/myofibroblastic neoplasms","volume":"42","author":"Michal","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAS.0000000000001002","article-title":"Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms","volume":"42","author":"Kao","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.012_bib0006","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/PAS.0000000000001927","article-title":"Superficial CD34-positive fibroblastic tumor: a clinicopathologic, immunohistochemical, and molecular study of 59 cases","volume":"46","author":"Anderson","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/modpathol.2013.139","article-title":"Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy","volume":"27","author":"Carter","year":"2014","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0008","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/his.13088","article-title":"Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series","volume":"70","author":"Lao","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0009","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/PAS.0000000000001207","article-title":"PRDM10-rearranged Soft Tissue Tumor: a Clinicopathologic Study of 9 Cases","volume":"43","author":"Puls","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2559.1994.tb01290.x","article-title":"Epithelioid benign fibrous histiocytoma of skin: clinicopathological analysis of 20 cases of a poorly known variant","volume":"24","author":"Gomez","year":"1994","journal-title":"Histopathology"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0011","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2015.49","article-title":"ALK rearrangement and overexpression in epithelioid fibrous histiocytoma","volume":"28","author":"Doyle","year":"2015","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.012_bib0012","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1600-0560.2011.01747.x","article-title":"EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall","volume":"38","author":"Doyle","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0013","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/bjd.13548","article-title":"Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions","volume":"172","author":"Jedrych","year":"2015","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.012_bib0014","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2017.191","article-title":"Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases","volume":"31","author":"Dickson","year":"2018","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/gcc.23038","article-title":"Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation","volume":"61","author":"Georgantzoglou","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2023.04.012_bib0016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.humpath.2021.12.004","article-title":"Analyzing the morphological spectrum of epithelioid fibrous histiocytoma and the immunohistochemical performance of the ALK D5F3 and ALK1 clones","volume":"120","author":"Moayed-Alaei","year":"2022","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0017","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/hupa.2001.25903","article-title":"Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes","volume":"32","author":"Fetsch","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.humpath.2016.10.016","article-title":"Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss\/deletions","volume":"60","author":"Agaimy","year":"2017","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cup.13773","article-title":"Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: a diagnostically exploitable marker","volume":"48","author":"Motanagh","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000478-198902000-00003","article-title":"Pleomorphic fibroma of the skin: a benign neoplasm with cytologic atypia. A clinicopathologic study of eight cases","volume":"13","author":"Kamino","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0021","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cup.12965","article-title":"Loss of retinoblastoma in pleomorphic fibroma: an immunohistochemical and genomic analysis","volume":"44","author":"Hinds","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0022","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/cup.13686","article-title":"Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations","volume":"47","author":"Cloutier","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0023","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12105-020-01242-z","article-title":"Inflammatory variant of atypical lipomatous tumor\/well-differentiated liposarcoma of the buccal mucosa: an overview and case report with a 10-year follow-up","volume":"15","author":"de Arruda","year":"2021","journal-title":"Head and Neck Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0024","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s12105-020-01171-x","article-title":"Well-differentiated\/dedifferentiated liposarcoma arising in the upper aerodigestive tract: 8 cases mimicking non-adipocytic lesions","volume":"14","author":"Fritchie","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.609515","article-title":"A retrospective study of superficial type atypical lipomatous tumor","volume":"7","author":"Mashima","year":"2020","journal-title":"Front Med"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0026","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0b013e3182417330","article-title":"Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors","volume":"36","author":"Thway","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.012_bib0027","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/PAS.0000000000000713","article-title":"MDM2 and CDK4 immunohistochemistry: should it be used in problematic differentiated lipomatous tumors: a new perspective","volume":"40","author":"Clay","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0028","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.humpath.2020.06.005","article-title":"Chromosomal microarray analysis of benign mesenchymal tumors with RB1 deletion","volume":"102","author":"Dusenbery","year":"2020","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0029","first-page":"2613","article-title":"Spindle cell lipoma: clinicopathologic characterization of 40 cases","volume":"12","author":"Chen","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.012_bib0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/cup.13512","article-title":"Low-fat and fat-free spindle cell lipomas in the oral cavity: immunohistochemical analysis and review of the literature","volume":"46","author":"Rocha","year":"2019","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.012_bib0031","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000478-199409000-00006","article-title":"Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases","volume":"18","author":"Dei Tos","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.012_bib0032","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/modpathol.2010.66","volume":"23","author":"Mentzel","year":"2010","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000770","article-title":"Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum","volume":"41","author":"Mari\u00f1o-Enriquez","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.012_bib0034","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/PAS.0000000000000936","volume":"41","author":"Creytens","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0035","series-title":"WHO Classification of Tumours Editorial Board ed. World Health Organization classification of Soft Tissue and Bone Tumours","first-page":"34","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumour","author":"Creytens","year":"2020"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.012_bib0036","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001706","article-title":"Atypical pleomorphic lipomatous tumor: expanding our current understanding in a clinicopathologic analysis of 64 cases","volume":"45","author":"Anderson","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0037","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jid.2019.12.027","article-title":"Human polyomavirus 6 with the Asian-Japanese genotype in cases of Kimura disease and angiolymphoid hyperplasia with eosinophilia","volume":"140","author":"Hashida","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1053\/j.semdp.2023.04.012_bib0038","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/DAD.0000000000001407","article-title":"Extramedullary Hematopoiesis: an Unusual Finding in Angiolymphoid Hyperplasia with Eosinophilia","volume":"41","author":"Johnson","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.012_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D32512046725","article-title":"Angiolymphoid hyperplasia with eosinophilia treated with Mohs micrographic surgery","volume":"25","author":"Trivedi","year":"2019","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.012_bib0040","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/PAS.0000000000000469","article-title":"Frequent FOS gene rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal","volume":"39","author":"Huang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0041","article-title":"Immunohistochemistry for FOSB and FOS is a useful ancillary tool in the diagnosis of epithelioid hemangioma but there are pitfalls in interpretation including expression in other vascular lesions","author":"Tsui","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0042","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.humpath.2017.10.023","article-title":"Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study","volume":"71","author":"Pradhan","year":"2018","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0043","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/DAD.0000000000001104","article-title":"Pseudomyogenic Hemangioendothelioma: case report and review of the literature","volume":"40","author":"Raftopoulos","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.012_bib0044","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1158\/1078-0432.CCR-17-3512","article-title":"Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma","volume":"24","author":"van IJzendoorn","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.012_bib0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","article-title":"FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma","volume":"41","author":"Hung","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0046","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13000-016-0530-2","article-title":"Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics","volume":"11","author":"Sugita","year":"2016","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0047","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41379-019-0368-8","article-title":"Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets","volume":"33","author":"Rosenbaum","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0048","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gcc.22839","article-title":"Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement","volume":"59","author":"Suurmeijer","year":"2020","journal-title":"GENES CHROMOSOMES & CANCER"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0049","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PAP.0000000000000228","article-title":"Epithelioid Vascular Tumors: a Review","volume":"26","author":"Shon","year":"2019","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0051","first-page":"159","article-title":"CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers","volume":"30","author":"Yus\u0131fl\u0131","year":"2014","journal-title":"Turk Patoloji Derg"},{"issue":"8","key":"10.1053\/j.semdp.2023.04.012_bib0052","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0053","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/modpathol.2011.134","volume":"25","author":"Mentzel","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0054","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2353\/ajpath.2010.090637","article-title":"MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema","volume":"176","author":"Manner","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/gcc.20827","article-title":"Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions","volume":"50","author":"Guo","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0056","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","article-title":"Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: a Clinicopathologic and Molecular Study of 115 Cases","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.012_bib0057","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/cup.13639","article-title":"Expanding the differential of superficial tumors with round-cell morphology: report of three cases of CIC-rearranged sarcoma, a potentially under-recognized entity","volume":"47","author":"Maloney","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.012_bib0058","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/cup.13656","article-title":"Superficial sarcomas with CIC rearrangement are aggressive neoplasms: a series of eight cases","volume":"47","author":"Ko","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.012_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100103","article-title":"Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners","volume":"36","author":"Linos","year":"2023","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0060","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/gcc.22172","article-title":"Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities","volume":"53","author":"Specht","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.012_bib0061","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","article-title":"Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics","author":"Hung","year":"2016","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.04.012_bib0062","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/modpathol.2016.155","article-title":"ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions","volume":"29","author":"Le Guellec","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0063","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000000772","article-title":"DUX4 Immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 fusion-positive round cell tumor","volume":"41","author":"Siegele","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0064","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/his.13252","article-title":"CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study","volume":"71","author":"Yoshida","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1053\/j.semdp.2023.04.012_bib0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/path.4701","article-title":"Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic\/haemangiopericytic pattern","volume":"238","author":"Haller","year":"2016","journal-title":"J Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0066","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13000-020-01031-w","article-title":"Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors","volume":"15","author":"Kang","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0067","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41379-021-01005-3","article-title":"Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements","volume":"35","author":"Tsai","year":"2022","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2023.04.012_bib0068","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/gcc.22877","article-title":"Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern","volume":"59","author":"Kao","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0069","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/PAS.0000000000001194","article-title":"Novel NTRK3 Fusions in Fibrosarcomas of Adults","volume":"43","author":"Yamazaki","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2023.04.012_bib0070","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/gcc.22767","article-title":"The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements","volume":"58","author":"Suurmeijer","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0071","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13666","article-title":"Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics","volume":"73","author":"Hung","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0072","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0073","first-page":"260","article-title":"NTRK-Rearranged soft tissue neoplasms: a review of evolving diagnostic entities and algorithmic detection methods","author":"Surrey","year":"2022","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0074","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/curroncol28030177","article-title":"Synovial sarcoma: a clinical review","volume":"28","author":"Gazendam","year":"2021","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.012_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.09.002","article-title":"Synovial sarcoma: defining features and diagnostic evolution","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2023.04.012_bib0076","article-title":"Diagnostic value of TLE1 in synovial sarcoma: a systematic review and meta-analysis","volume":"7192347","author":"El Beaino","year":"2020","journal-title":"Sarcoma"},{"issue":"6","key":"10.1053\/j.semdp.2023.04.012_bib0077","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1309\/AJCP45SSNAOPXYXU","article-title":"Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics","volume":"135","author":"Foo","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0078","first-page":"167","article-title":"S-100 protein reactivity in synovial sarcomas\u2014a potentially frequent diagnostic pitfall","volume":"4","author":"Guillou","year":"1996","journal-title":"Applied Immunohistochemistry"},{"issue":"7","key":"10.1053\/j.semdp.2023.04.012_bib0079","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000001447","article-title":"A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma","volume":"44","author":"Baranov","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/PAS.0000000000001628","article-title":"The SS18-SSX antibody has perfect specificity for the SS18-SSX fusion protein: a validation study of 609 neoplasms including 2 unclassified tumors with SS18-non-SSX fusions","volume":"45","author":"Perret","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.04.012_bib0081","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/PAS.0000000000001011","article-title":"SWI\/SNF chromatin-remodeling complex status in SMARCB1\/INI1-preserved epithelioid sarcoma","volume":"42","author":"Kohashi","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.04.012_bib0082","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PAP.0000000000000102","article-title":"Epithelioid sarcoma: diagnostic features and genetics","volume":"23","author":"Thway","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.04.012_bib0083","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.humpath.2014.10.010","article-title":"ERG and SALL4 expressions in SMARCB1\/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor","volume":"46","author":"Kohashi","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0084","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2013.161","article-title":"ERG and FLI1 protein expression in epithelioid sarcoma","volume":"27","author":"Stockman","year":"2014","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.04.012_bib0085","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/PAS.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:23:26Z","timestamp":1760037806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257023000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0740257023000436"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.04.012","relation":{},"ISSN":["0740-2570"],"issn-type":[{"type":"print","value":"0740-2570"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of immunohistochemical studies in diagnosing emerging superficial mesenchymal neoplasms","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}